These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 6620042)
1. The Water for Injection System at the Upjohn Company. Coates JL; Dover FN; Ruley WB J Parenter Sci Technol; 1983; 37(4):113-6. PubMed ID: 6620042 [No Abstract] [Full Text] [Related]
3. Design control and validation of a facility for sterile clinical trial preparations. Staines L J Parenter Sci Technol; 1984; 38(3):109-14. PubMed ID: 6747778 [No Abstract] [Full Text] [Related]
4. Drug information services at the Upjohn Company. Baker RP; Gurwich EL; Depew CC Am J Hosp Pharm; 1990 Sep; 47(9):1999-2001. PubMed ID: 2220852 [No Abstract] [Full Text] [Related]
5. A review of current technology in parenteral manufacturing. Akers JE; Agalloco JP; Carleton FJ; Korczynski MS J Parenter Sci Technol; 1988; 42(2):53-6. PubMed ID: 3385542 [No Abstract] [Full Text] [Related]
6. IV fluidmakers: preparation of sterile water for injection in a field setting. Burrows WD; Nelson JH J Parenter Sci Technol; 1993; 47(3):124-9. PubMed ID: 8360804 [TBL] [Abstract][Full Text] [Related]
7. A multicentred investigation of clean air requirements for terminally sterilized pharmaceuticals. Whyte W J Parenter Sci Technol; 1983; 37(4):138-44. PubMed ID: 6620047 [No Abstract] [Full Text] [Related]
8. New concepts in the manufacturing and sterilization of LVP's in plastic bottles. Uotila JA; Santasalo NT J Parenter Sci Technol; 1981; 35(4):170-5. PubMed ID: 7277131 [No Abstract] [Full Text] [Related]
9. Validation and control of non-standard sterilization processes. Committee on Microbial Purity. FIP (International Pharmaceutical Federation). J Parenter Sci Technol; 1993; 47(1):9-15. PubMed ID: 8445502 [TBL] [Abstract][Full Text] [Related]
10. The advisory role of FDA district offices in the planning of a new parenteral facility. Tetzlaff RF J Parenter Sci Technol; 1984; 38(3):94-7. PubMed ID: 6747781 [No Abstract] [Full Text] [Related]
11. The influence of clean room design on product contamination. Whyte W J Parenter Sci Technol; 1984; 38(3):103-8. PubMed ID: 6747777 [No Abstract] [Full Text] [Related]
12. Gap closes between prices paid for I.V.s: '82 survey. Kuntz EF Mod Healthc; 1982 Nov; 12(11):38-9, 42. PubMed ID: 10257212 [No Abstract] [Full Text] [Related]
13. Problems in purchasing IV solutions. Decker R Hosp Purch Manage; 1980 Jun; 5(6):15-7. PubMed ID: 10246726 [No Abstract] [Full Text] [Related]
14. The problems with solutions. Hosp Purch Manage; 1982 Oct; 7(10):12-5. PubMed ID: 10257089 [No Abstract] [Full Text] [Related]
15. I.V. prices will rise as competitors drop out of market, analyst warns. Kuntz EF Mod Healthc; 1982 Oct; 12(10):24-5. PubMed ID: 10256961 [No Abstract] [Full Text] [Related]
16. Parenteral drugs--commerce and science. de Haen P J Parenter Drug Assoc; 1978; 32(1):9-14. PubMed ID: 246930 [No Abstract] [Full Text] [Related]
17. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association. J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417 [No Abstract] [Full Text] [Related]
18. [Apparatus for sterilization and heating of liquids used in urological endoscopic procedures]. Jeromin L; Stapor K; Kloczkowski K; Kubiak M Pol Tyg Lek; 1979 Sep; 34(36):1435-6. PubMed ID: 514854 [No Abstract] [Full Text] [Related]
19. Hospital supply industry review...focus on the hospital pharmacist. Friedman WR Surg Bus; 1980 Mar; 43(3):22-3. PubMed ID: 10246013 [No Abstract] [Full Text] [Related]